Search company, investor...

NeoDiagnostix

neodiagnostix.com

About NeoDiagnostix

NeoDiagnostix develops molecular diagnostic and prognostic tests for the treatment of cancer. The company's test results eliminate the ambiguity experienced in millions of samples analyzed by traditional cytomorphology-based cell analyses. The company is committed to providing physicians with information that will improve patient care and treatment.

Headquarters Location

9700 Great Seneca Highway

Rockville, Maryland, 20850,

United States

Missing: NeoDiagnostix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NeoDiagnostix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing NeoDiagnostix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NeoDiagnostix is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

NeoDiagnostix Patents

NeoDiagnostix has filed 13 patents.

The 3 most popular patent topics include:

  • Gynaecological cancer
  • Infectious causes of cancer
  • Rare diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/17/2019

12/7/2021

Transcription factors, Molecular biology, Genetics, Infectious causes of cancer, Gynaecological cancer

Grant

Application Date

3/17/2019

Grant Date

12/7/2021

Title

Related Topics

Transcription factors, Molecular biology, Genetics, Infectious causes of cancer, Gynaecological cancer

Status

Grant

NeoDiagnostix Frequently Asked Questions (FAQ)

  • Where is NeoDiagnostix's headquarters?

    NeoDiagnostix's headquarters is located at 9700 Great Seneca Highway, Rockville.

  • Who are NeoDiagnostix's competitors?

    Competitors of NeoDiagnostix include AltheaDx, CivaTech Oncology, Decipher Biosciences, Exagen, Foundation Medicine and 15 more.

Compare NeoDiagnostix to Competitors

N
Nanogen Adavanced Diagnostics S.r.l.

At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.

C
Cellpoint Diagnostics

CellPoint Diagnostics is developing diagnostic, monitoring, and molecular analytical tools for cancer. Its technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients.

T
TheraGenetics

theraGenetics is a personalized medicine diagnostics company developing pharmacogenetic tests to guide and improve the treatment of central nervous system (CNS) disorders; matching the medication to the patient.

E
Expression Diagnostics

XDx is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. Per the company, they have developed a proprietary method of utilizing gene expression in blood that aims to provide a new tool for physicians to manage the care of heart transplant patients. The molecular expression technology developed and implemented by XDx in heart transplant patient management is currently being explored to assist with other diseases that involve the immune system.

T
Tympany

Tympany is developing automated, hearing, diagnostic technology. Tympany aims to improve early detection of hearing loss, increase access to diagnostics, and facilitate the ease and convenience of personalized treatment. The company is located in The Woodlands, Texas, with regional offices throughout the U.S

h
hanse chemie GmbH

Micronics, Inc. is a developer of near patient in vitro diagnostic products for disease diagnosis, prognosis and treatment monitoring. The Company employs a core patent estate in microfluidics -- the ability to miniaturize complex tests onto credit card size disposable devices. Per the company, tests that today take hours to days in a central laboratory environment are processed on a Micronics disposable device in seconds to minutes.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.